Download PDF
Synlett 2012(5): 783-787  
DOI: 10.1055/s-0031-1290339
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Total Synthesis and Stereochemical Revision of Burkholdac A

Junyang Liua, Xiao Maa, Yuqing Liub, Zhuo Wangb, Shuqin Kwongb, Qi Rena, Shoubin Tanga, Yi Menga, Zhengshuang Xu*a,b, Tao Ye*a,b
a Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, University Town of Shenzhen, Xili, Nanshan District, Shenzhen, 5180505, P. R. of China
b Department of Applied Biology & Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong, P. R. of China
Fax: +85222641912; e-Mail: bctaoye@inet.polyu.edu.hk; e-Mail: xuzs@szpku.edu.cn;
Further Information

Publication History

Received 13 December 2011
Publication Date:
08 February 2012 (online)

    Permissions and Reprints All articles of this category

Abstract

A stereocontrolled total synthesis of burkholdac A was completed, leading to a revision of the reported stereochemistry.

Key words

burkholdac A - total synthesis - antitumor - stereochemical assignment

    References and Notes

  • 1 Montaser R. Hendrik L. Future Med. Chem.  2011,  3:  1475 
    Google Scholar
  • 2 Suyama TL. Gerwick WH. McPhail KL. Bioorg. Med. Chem.  2011,  19:  6675 
    Google Scholar
  • 3 Maier ME. Nat. Prod. Rep.  2009,  26:  1105 
    Google Scholar
  • 4a Wang L. Xu ZS. Ye T. Org. Lett.  2011,  13:  2506 
    Google Scholar
  • 4b Liu H. Liu Y. Xu ZS. Ye T. Chem. Commun.  2010,  46:  7486 
    Google Scholar
  • 4c Li S. Chen Z. Xu ZS. Ye T. Chem. Commun.  2010,  46:  4773 
    Google Scholar
  • 4d Gao XG. Liu Y. Kwong S. Xu ZS. Ye T. Org. Lett.  2010,  12:  3018 
    Google Scholar
  • 4e Chen Z. Song L. Xu ZS. Ye T. Org. Lett.  2010,  12:  2036 
    Google Scholar
  • 4f Jin Y. Liu YQ. Wang Z. Kwong S. Xu ZS. Ye T. Org. Lett.  2010,  12:  1100 
    Google Scholar
  • 4g Liang S. Xu ZS. Ye T. Chem. Commun.  2010,  46:  153 
    Google Scholar
  • 4h Chen B. Dai L. Zhang H. Tan W. Xu ZS. Ye T. Chem. Commun.  2010,  46:  574 
    Google Scholar
  • 4i Li S. Liang S. Tan WF. Xu ZS. Ye T. Tetrahedron  2009,  65:  2695 
    Google Scholar
  • 4j Li S. Liang S. Xu ZS. Ye T. Synlett  2008,  569 
    Google Scholar
  • 4k Ren Q. Dai L. Zhang H. Tan W. Xu ZS. Ye T. Synlett  2008,  2379 
    Google Scholar
  • 4l Chen Z. Ye T. New J. Chem.  2006,  30:  518 
    Google Scholar
  • 4m Pang HW. Xu ZS. Chen ZY. Ye T. Lett. Org. Chem.  2005,  2:  699 
    Google Scholar
  • 4n Peng YG. Pang HW. Xu ZS. Ye T. Lett. Org. Chem.  2005,  2:  703 
    Google Scholar
  • 4o Peng YG. Pang HW. Ye T. Org. Lett.  2004,  6:  3781 
    Google Scholar
  • 4p Xu ZS. Chen ZY. Ye T. Tetrahedron: Asymmetry  2004,  15:  355 
    Google Scholar
  • 4q Xu ZS. Peng YG. Ye T. Org. Lett.  2003,  5:  2821 
    Google Scholar
  • 4r Chen ZY. Deng JG. Ye T. ARKIVOC  2003,  (vii):  268 
    Google Scholar
  • 5 Benelkebir H. Donlevy AM. Packham G. Ganesan A. Org. Lett.  2011,  13:  6334 
    Google Scholar
  • 6 Biggins JB. Gleber CD. Brady SF. Org. Lett.  2011,  13:  1536 
    Google Scholar
  • 7a Chen Y. Gambs C. Abe Y. Wentworth P. Janda KD. J. Org. Chem.  2003,  68:  8902 
    Google Scholar
  • 7b Cheng YQ. Yang M. Matter AM. Appl. Environ. Microbiol.  2007,  73:  3460 
    Google Scholar
  • 7c Narita K. Kikuchi T. Watanabe K. Takizawa T. Oguchi T. Kudo K. Matsuhara K. Abe H. Yamori T. Yoshida M. Katoh T. Chemistry  2009,  15:  11174 
    Google Scholar
  • 7d Wang C. Wesener SR. Zhang H. Cheng YQ. Chem. Biol.  2009,  16:  585 
    Google Scholar
  • 8 Brooks DW. Lu LDL. Masamune S. Angew. Chem., Int. Ed. Engl.  1979,  18:  72 
    Google Scholar
  • 9 Yurek-George A. Habens F. Brimmell M. Packham G. Ganesan A. J. Am. Chem. Soc.  2004,  130:  1026 
    Google Scholar
  • 10 Keck GE. Boden EP. J. Org. Chem.  1985,  50:  2394 
    Google Scholar
  • 11a Nagao Y. Hagiwara Y. Kumagai T. Ochiai M. Inoue T. Hashimoto K. Fujita E. J. Org. Chem.  1986,  51:  2391 
    Google Scholar
  • 11b White JD. Martin WHC. Lincoln C. Yang J. Org. Lett.  2007,  9:  3481 
    Google Scholar
  • 11c Janssen D. Kalesse M. Synlett  2007,  2667 
    Google Scholar
  • 11d Scheerer JR. Lawrence JF. Wang GC. Evans DA. J. Am. Chem. Soc.  2007,  129:  8968 
    Google Scholar
  • 11e Smith AB. Simov V. Org. Lett.  2006,  8:  3315 
    Google Scholar
  • 11f Paterson I. Steven A. Luckhurst CA. Org. Biomol. Chem.  2004,  2:  3026 
    Google Scholar
  • 11g Romo D. Choi NS. Li S. Buchler I. Shi Z. Liu JO. J. Am. Chem. Soc.  2004,  126:  10582 
    Google Scholar
  • 11h Velazquez F. Olivo HF. Curr. Org. Chem.  2002,  6:  303 
    Google Scholar
  • 11i Sinz CJ. Rychnovsky SD. Angew. Chem. Int. Ed.  2001,  40:  3224 
    Google Scholar
  • 11j Aiguadé J. González A. Urpí F. Vilarrasa J. Tetrahedron Lett.  1996,  37:  8949 
    Google Scholar
  • 12a Shiina I. Kubota M. Oshiumi H. Hashizume M. J. Org. Chem.  2004,  69:  1822 
    Google Scholar
  • 12b Shiina I. Fukui S. Sasaki A. Nat. Protoc.  2007,  2:  2312 
    Google Scholar
13

Synthesis of the Proposed Burkholdac A (1)
Compound 2 (46 mg, 0.04 mmol) was dissolved in MeOH-CH2Cl2 (50 mL, 1:9) and added to a vigorously stirred solution of I2 (126 mg, 0.50 mmol) in MeOH-CH2Cl2 (200 mL, 1:9) at r.t. over 0.5 h. After 10 min, the reaction was quenched by addition of sat. aq solution of Na2S2O3 (20 mL) and concentrated in vacuo. The residue was extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with sat. aq solution of Na2S2O3 (20 mL) and brine (30 mL), dried over anhyd Na2SO4 and concentrated in vacuo. The residue was dissolved in pyridine (1 mL), after HF˙py (0.8 mL) was added at 0 ˚C, the reaction mixture was stirred at r.t. for 12 h. All volatiles were removed in vacuo; the residue was diluted with EtOAc (100 mL) and washed with HCl (20 mL, 1.0 M in H2O) and brine (20 mL), dried over anhyd Na2SO4 and concentrated in vacuo. The residue was purified by flash chromatography (eluted with EtOAc-hexanes-MeOH = 3:1:0.3) to provide the desired compound 1 (13.4 mg, 63% yield over 2 steps) as a white amorphous solid: [α]D ²0 -166.5 (c 0.35, MeOH). ¹H NMR (400 MHz, CD3CN): δ = 7.71 (d, J = 5.4 Hz, 1 H), 7.09 (d, J = 9.8 Hz, 1 H), 7.02 (br s, 1 H), 5.90 (br s, 1 H), 5.77 (d, J = 15.5 Hz, 1 H), 5.58 (dd, J = 6.1, 2.3 Hz, 1 H), 4.74 (br s, 1 H), 3.97-3.92 (m, 1 H), 3.83 (ddd, J = 10.2, 6.5, 4.0 Hz, 1 H), 3.68 (td, J = 10.3, 3.0 Hz, 1 H), 3.40-3.22 (m, 2 H), 2.73-2.67 (m, 2 H), 2.64-2.56 (m, 3 H), 2.51-2.43 (m, 3 H), 2.40-2.26 (m, 3 H), 2.18-2.08 (m, 2 H), 2.06 (s, 3 H), 0.83 (d, J = 0.8 Hz, 3 H), 0.81 (d, J = 1.0 Hz, 3 H) ppm. ¹³C NMR (100 MHz, CD3CN): δ = 172.4, 171.4, 171.2, 170.8, 131.9, 131.0, 70.0, 69.6, 60.1, 54.9, 54.8, 43.7, 41.2, 41.2, 41.1, 31.4, 29.1, 28.3, 20.8, 15.6, 15.0 ppm. ESI-HRMS m/z calcd for C22H36N3O6S3 + [M + H]+: 534.1761; found: 534.1757.

14

The Analytical Data of the Revised Burkholdac A ( epi- 1)
[α]D ²0 -54.0 (c 0.23, MeOH). ¹H NMR (500 MHz, CD3CN): δ = 7.51 (s, 1 H), 7.41 (d, J = 6.9 Hz, 1 H), 6.90 (d, J = 8.9 Hz, 1 H), 6.12-6.06 (m, 1 H), 5.90 (d, J = 15.5 Hz, 1 H), 5.56-5.54 (m, 1 H), 4.70 (td, J = 9.2, 3.6 Hz, 1 H), 4.47-4.43 (m, 1 H), 4.18-4.13 (m, 1 H), 3.33-3.30 (m, 1 H), 3.21 (d, J = 10.5 Hz, 1 H), 3.13 (d, J = 14.0 Hz, 1 H), 2.96 (dd, J = 13.1, 7.2 Hz, 1 H), 2.86-2.57 (m, 8 H), 2.25 (dq, J = 13.6, 6.8 Hz, 1 H), 2.10 (s, 3 H), 2.08-2.01 (m, 2 H), 0.96 (d, J = 6.8 Hz, 3 H), 0.87 (d, J = 6.8 Hz, 3 H) ppm. ¹³C NMR (125 MHz, CD3CN): δ = 173.0, 172.2, 171.7, 170.1, 132.4, 131.5, 71.7, 69.0, 63.2, 56.8, 56.4, 41.8, 41.1, 40.8, 33.3, 31.2, 30.6, 30.5, 21.1, 19.8, 15.2 ppm. ESI-HRMS: m/z calcd for C22H36N3O6S3 + [M + H]+: 534.1761; found: 534.1760.